Recordati gets €10.9bn takeover bid from private equity firm Recordati has received a takeover offer from private equity group CVC that, if completed, would delist it from the Italian stock exchange.

#Recordati has received an unsolicited takeover offer from #privateequity group #CVCCapitalPartners that, if completed, would delist the #pharma group from the #Italian #stockexchange.

Moderna、mRNA-3927でRecordatiと協業──プロピオン酸血症（PA）治療の後期開発とグローバル商業化へ | STELLANEWS.LIFE STELLANEWS.LIFE（ステラニュース・ライフ）は、科学や技術、医薬品分野における最新の研究成果や発見 | STELLANEWS.LIFE（ステラニュース・ライフ）は、科学や技術、医薬品分野における最新の研究成果や発見

Moderna announced a collaboration with Recordati for mRNA-3927, an investigational therapy for propionic acidemia (PA), to advance late-stage clinical development and global commercialization.

stellanews.life/technology/8...

#PropionicAcidemia #mRNA #Moderna #Recordati #ClinicalDevelopment

【Moderna、mRNA-3927でRecordatiと協業、プロピオン酸血症治療の開発後期と商業化へ】

✔ プロピオン酸血症（PA）を対象とするmRNA-3927について、Recordati社と提携 ✔ 最終段階の臨床開発の推進、および承認後のグローバルな商業化を目指す枠組み ✔ 本件は企業ブログ（IR Insights）および動画にて概要を提示

#プロピオン酸血症 #mRNA治療 #Moderna #Recordati #希少疾患 #臨床開発

Gedeon Richter UK takes over UK rights to cariprazine - PharmaTimes Company strengthens its neuropsychiatry portfolio after marketing transfer from Recordati

#mentalhealth #GedeonRichter #UK #cariprazine #neuropsychiatry #marketingtransfer #Recordati #GedeonRichterUK #RecordatiPharmaceuticals #UKpromotion #MarketingAuthorisation #schizophrenia #adults #centralnervoussystem #CNS #chronicmentalhealthcondition
zurl.co/pROEi

モデルナ、Recordati社と希少疾患向け治療薬の商業化で提携を発表 モデルナがRecordati社との提携を通じて、プロピオン酸血症治療薬mRNA-3927のグローバル商業化に向けた戦略を進める。契約内容や期待される効果について詳しく解説。

モデルナ、Recordati社と希少疾患向け治療薬の商業化で提携を発表 #モデルナ #Recordati #像血症治療

モデルナがRecordati社との提携を通じて、プロピオン酸血症治療薬mRNA-3927のグローバル商業化に向けた戦略を進める。契約内容や期待される効果について詳しく解説。

New Insights on the Long-Term Safety of ENJAYMO® in Cold Agglutinin Disease Presented at ASH 2025 Recordati Rare Diseases unveils long-term safety data of ENJAYMO® (sutimlimab-jome) for cold agglutinin disease at the ASH Annual Meeting.

New Insights on the Long-Term Safety of ENJAYMO® in Cold Agglutinin Disease Presented at ASH 2025 #USA #Bridgewater #Recordati #ENJAYMO #Cold_Agglutinin_Disease

Borsa: Milano chiude in rialzo con Recordati in testa Maglia nera Stellantis, ancora pesanti Mps e Mediobanca

➡️ Leggi l'articolo: #Borsa #Milano #Recordati #Stellantis #MPS

Borsa: Milano tiene (+0,4%), attesa per dazi e Ucraina Bene Recordati, positive Tim e Unipol. Pesante Leonardo

➡️ Leggi l'articolo: #Borsa #Milano #Dazi #Ucraina #Recordati

Piazza Affari cauta a metà seduta: Ftse Mib in lieve rialzo, Recordati brilla Ftse Mib cresce dello 0,1% a metà seduta, Recordati spicca con +2,46% grazie a JpMorgan. Leonardo e Amplifon in calo.

➡️ Leggi l'articolo: #PiazzaAffari #FtseMib #Recordati #JpMorgan #Leonardo

Piazza Affari stabile a metà seduta: Recordati in crescita, Leonardo in calo Piazza Affari vede l'indice Ftse Mib crescere dello 0,1%, con Recordati in rialzo del 2,46% e Leonardo in calo del 2,39%.

➡️ Leggi l'articolo: #PiazzaAffari #FtseMib #Recordati #Leonardo #mercatoFinanziario

Recordati Presents ISTURISA® for Cushing's Syndrome at AACE Annual Meeting Recordati Rare Diseases Inc. announces new insights on ISTURISA® for Cushing's syndrome treatment, highlighted at AACE Annual Meeting 2025.

Recordati Presents ISTURISA® for Cushing's Syndrome at AACE Annual Meeting #USA #Orlando #Cushing's_Syndrome #ISTURISA #Recordati

Piazza Affari debole con Ftse Mib a 38.538 punti, Amplifon e Italgas in evidenza Piazza Affari parte debole, Ftse Mib a 38.538 punti. Amplifon e Italgas in rialzo, Recordati e Fineco in calo.

➡️ Leggi l'articolo: #PiazzaAffari #FTSEMib #Amplifon #Italgas #Recordati

Vendite in calo su Piazza Affari: Recordati e farmaceutici europei in difficoltà Piazza Affari perde il 3,7% a causa della guerra commerciale e dei nuovi dazi Usa. Recordati e farmaceutici europei in forte ribasso.

➡️ Leggi l'articolo: #PiazzaAffari #Recordati #farmaceutici #mercati #dazi

Piazza Affari in rialzo: Ftse Mib cresce dello 0,44%, Recordati e Stm in evidenza Piazza Affari mantiene il segno positivo con Ftse Mib a +0,44%. Crescono Recordati e Stm, mentre Pirelli e Italgas calano.

➡️ Leggi l'articolo: #PiazzaAffari #FtseMib #Recordati #Stm #Pirelli

A #PiazzaAffari molto bene #Recordati con un +5,35% e #Saipem +3,52%, anche #Stellantis +1,6% in recupero dopo le pesanti perdite dei giorni scorsi.

#Milano #Borse #Euro #Azioni #Economia #Finanza